Browsing by Author Sun, Zhuoxin

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)Citation
2016Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to VCoates, Alan; Castiglione-Gertsch, Monica; Colleoni, Marco; Forbes, John F.; Gelber, Richard; Gianni, Lorenzo; Goldhirsch, Aron; Karlsson, Per; Price, Karen; Sun, Zhuoxin; Thurlimann, B.; School of Public Health: Public HealthAnnual hazard rates of recurrence for breast cancer during 24 years of follow-up: Results from the international breast cancer study group trials I to V, Journal of Clinical Oncology, vol.34, 9, 2016,pp 927-935
2009Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trialCoates, Alan; Campone, N; Castiglione-Gertsch, Monica; Forbes, John; Hawle, H; Mouridsen, Henning; Paridaens, R.J.; Price, K. N.; Rabaglio, Manuela; Sun, Zhuoxin; Thurlimann, Beat; School of Public Health: Public HealthBone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial, Annals of Oncology, vol.20, 9,pp 1489-1498
2014Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequencesCoates, Alan; Campone, Mario; Debled, M.; DeCensi, Andrea; et al, Various; Guerrieri-Gonzaga, Aliana; McIntosh, Christina; Monnier, Alain; Schönenberger, Astrid; Sun, Zhuoxin; Thurlimann, B.; Tondini, Carlo; School of Public Health: Public HealthBone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences, Breast Cancer Research and Treatment, vol.144, 2, 2014,pp 321-329
2007Cardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 TrialCoates, Alan; Castiglione-Gertsch, Monica; et, al; Forbes, John F.; Keshaviah, Aparna; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Rabaglio, Manuela; Sun, Zhuoxin; Thurlimann, Beat; School of Public Health: Public HealthCardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 Trial, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(36),2007,pp 5715-5722
2011Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trialCoates, Alan; Aldridge, Julie; Bernhard, Jurg; Cardoso, Fatima; Gelber, RD; Goldhirsch, Aron (Prof); Harvey, V; Pagani, O.; Phillips, Kelly-Anne; Price, K N; Ribi, Karin; Sun, Zhuoxin; Thompson, Alastair; Thurlimann, B.; School of Public Health: Public HealthCognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial, Breast Cancer Research and Treatment, vol.126, 1, 2011,pp 221-226
2010Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialCoates, Alan; Bernhard, Jurg; Cardoso, Fatima; Gelber, Richard D. (Prof); Goldhirsch, A; Harvey, V; Pagani, O.; Phillips, Kelly-Anne; Price, Karen; Ribi, Karen; Stephens, Alisa; Sun, Zhuoxin; Thompson, Alastair; Thurlimann, B.; School of Public Health: Public HealthCognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial, The Breast, vol.19, 5,pp 388-395
2009The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.Coates, Alan; Aebi, S; Basser, R; Cinieri, S.; Colleoni, Marco; et al, various; Gelber, RD; Green, M; Martinelli, G; Peccatori, F.; Sun, Zhuoxin; School of Public Health: Public HealthThe effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up., Annals of Oncology, vol.20, 8,pp 1344-1351
2008Letrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 TrialCoates, Alan; Castiglione-Gertsch, Monica; Chirgwin, Jacquie H; Colleoni, Marco; Crivellari, Diana; Del Mastro, Lucia; Forbes, John F.; Gelber, Richard D. (Prof); Gladieff, Laurence; Goldhirsch, Aron; Lang, Istvan; Mauriac, Louis; Mouridsen, Henning; Paridaens, Robert; Price, Karen; Rabaglio, Manuela; Smith, Ian (Prof); Sun, Zhuoxin; Thurlimann, Beat; School of Public Health: Public HealthLetrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 Trial, Journal of Clinical Oncology, vol.26, 12, 2008,pp 1972-1979
2011Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancerCoates, Alan; Braun, D; Castiglione-Gertsch, M; Collins, John; Crivellari, Diana; et al, various; Gelber, RD; Karlsson, Per; Price, K. N.; Rabaglio, Manuela; Sun, Zhuoxin; School of Public Health: Public HealthLong-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer, Annals of Oncology, vol.22, 10, 2011,pp 2216-2226
2012Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXCoates, Alan; O'Toole, Sandra; Castiglione-Gertsch, Monica; Gelber, Richard; Goldhirsch, Aron (Prof); Gusterson, Barry; Millar, E. K. A.; Molloy, T; Musgrove, Elizabeth A.; Regan, Meredith M.; Sun, Zhuoxin; Sutherland, Robert L.; Viale, Giuseppe; School of Public Health: Public Health; Central Clinical School: PathologyPrognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX, Breast Cancer Research, vol.14, 6, 2012,pp 1-12